A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye Disease

NCT04498182 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
369
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Aerie Pharmaceuticals